Angion Biomedica Statistics Share Statistics Angion Biomedica has 30.11M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 30.11M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 20.9M Failed to Deliver (FTD) Shares 178 FTD / Avg. Volume 1.82%
Short Selling Information The latest short interest is 177.59K, so 0% of the outstanding
shares have been sold short.
Short Interest 177.59K Short % of Shares Out n/a Short % of Float 0.88% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.24 and the forward
PE ratio is null.
Angion Biomedica's PEG ratio is
0.
PE Ratio -0.24 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -1.08 P/FCF Ratio -0.33 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Angion Biomedica.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.8,
with a Debt / Equity ratio of -0.53.
Current Ratio 1.8 Quick Ratio 1.8 Debt / Equity -0.53 Debt / EBITDA -0.13 Debt / FCF -0.16 Interest Coverage 98.87
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-17.3M Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.6, so Angion Biomedica's
price volatility has been higher than the market average.
Beta 0.6 52-Week Price Change n/a 50-Day Moving Average 0.71 200-Day Moving Average 0.82 Relative Strength Index (RSI) 71.81 Average Volume (20 Days) 9,772
Income Statement
Revenue n/a Gross Profit n/a Operating Income -44.99M Net Income -51.9M EBITDA -44.99M EBIT n/a Earnings Per Share (EPS) -4.25
Full Income Statement Balance Sheet The company has 17.62M in cash and 6.01M in
debt, giving a net cash position of 11.61M.
Cash & Cash Equivalents 17.62M Total Debt 6.01M Net Cash 11.61M Retained Earnings -194.1M Total Assets 28.14M Working Capital 9.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -37.07M
and capital expenditures -87K, giving a free cash flow of -37.16M.
Operating Cash Flow -37.07M Capital Expenditures -87K Free Cash Flow -37.16M FCF Per Share -3.04
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ANGN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ANGN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 2, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 2, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -16 Piotroski F-Score 4
